Emily A Collin

Title: Inventor Spotlight: Emily A. Collin

Introduction

Emily A. Collin, an innovative inventor based in Windom, Minnesota, has made significant strides in the field of virology. With her dedicated research, she has contributed to the understanding and development of influenza C virus vaccines. Her work not only addresses critical health concerns but also paves the way for further research in the domain.

Latest Patents

Emily holds a patent for a novel influenza C virus and vaccine, characterized by low homology to any previously identified influenza C strains. The invention demonstrates that this virus can infect pigs and be transmitted between them, challenging the common belief that influenza C primarily affects humans. Noteworthy findings indicate that around 10% of pigs and 30% of humans possess antibodies against this virus. Additionally, her research showcases that the virus can be transmitted in ferrets, which serve as a model for human infection studies. Emily's patent also includes a partial genome of the novel influenza C virus and a detection method for identifying this virus in animals.

Career Highlights

Emily A. Collin’s career is marked by her commitment to advancing our understanding of infectious diseases. Through her role at Newport Laboratories, she has engaged in groundbreaking research that contributes to both veterinary and human health. Her capacity to innovate and develop new methodologies has reinforced her reputation as a respected figure within her field.

Collaborations

Throughout her career, Emily has collaborated with esteemed colleagues, including Randy R. Simonson and Benjamin Matthew Hause. Their joint efforts have facilitated the progress of research on influenza C, ensuring that multiple perspectives and expert insights contribute to the innovations being developed.

Conclusion

Emily A. Collin exemplifies the profound impact that inventors can have on public health through research and innovation. Her contributions to the study of the influenza C virus not only enlighten our understanding but also provide critical insights into vaccine development. As her career continues to evolve, the scientific community eagerly anticipates her future contributions and the positive effects they will have on global health.